STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE II PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE II PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE II PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to stop prostate cancer from coming back after surgery
Disease control OngoingThis study tests a special type of radiation called stereotactic body radiotherapy (SBRT) in men who have had their prostate removed but show signs of cancer returning (rising PSA). The goal is to see if SBRT can control the cancer and delay or avoid further treatments. About 92 …
Matched conditions: STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Proton beam breakthrough: fewer sessions, same cancer control?
Disease control OngoingThis study tested a shorter, high-dose course of proton beam radiation in 241 men with early-stage prostate cancer that hasn't spread. The goal was to see if this approach is safe and effective at controlling the cancer while causing fewer side effects. Participants received targ…
Matched conditions: STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New radiation approach may cut prostate cancer treatment time
Disease control OngoingThis study compares two types of radiation therapy for men with early-stage prostate cancer. One method uses fewer, higher-dose treatments (SBRT), while the other uses more frequent, lower-dose sessions. The goal is to see which approach better controls the cancer while causing f…
Matched conditions: STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:53 UTC